Primecap Management CO Liva Nova PLC Transaction History

Primecap Management CO

$126 Billion
Q3 2025

A detailed history of Primecap Management CO transactions in Liva Nova PLC stock. As of the latest transaction made, Primecap Management CO holds 4,444,832 shares of LIVN stock, worth $246 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

4,444,832

Previous 4,641,352 4.23%

Holding current value

$246 Million

Previous $209 Million 11.42%

% of portfolio

0.18%

Previous 0.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$41.13 - $58.72 $8.08 Million - $11.5 Million	-196,520 Reduced 4.23%	4,444,832 $233 Million
Q2 2025 Aug 11, 2025	BUY	$33.85 - $47.6 $1.12 Million - $1.57 Million	32,942 Added 0.71%	4,641,352 $209 Million
Q1 2025 May 09, 2025	SELL	$37.02 - $50.73 $5.39 Million - $7.39 Million	-145,650 Reduced 3.06%	4,608,410 $181 Million
Q4 2024 Feb 10, 2025	SELL	$45.7 - $53.85 $39.9 Million - $47.1 Million	-873,746 Reduced 15.53%	4,754,060 $220 Million
Q3 2024 Nov 08, 2024	SELL	$43.38 - $54.59 $15.3 Million - $19.3 Million	-353,394 Reduced 5.91%	5,627,806 $296 Million

Q2 2024 Aug 09, 2024	BUY	$51.76 - $64.15 $2.28 Million - $2.83 Million	44,049 Added 0.74%	5,981,200 $328 Million
Q1 2024 May 13, 2024	BUY	$48.6 - $57.12 $7.09 Million - $8.33 Million	145,871 Added 2.52%	5,937,151 $332 Million
Q4 2023 Feb 09, 2024	BUY	$43.45 - $53.66 $257,224 - $317,667	5,920 Added 0.1%	5,791,280 $300 Million
Q3 2023 Nov 13, 2023	BUY	$50.12 - $58.87 $19.8 Million - $23.3 Million	395,940 Added 7.35%	5,785,360 $306 Million
Q2 2023 Aug 11, 2023	BUY	$42.28 - $51.43 $9.02 Million - $11 Million	213,320 Added 4.12%	5,389,420 $277 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $23.7 Million - $33.8 Million	581,183 Added 12.65%	5,176,100 $226 Million
Q4 2022 Feb 13, 2023	BUY	$43.88 - $56.16 $799,800 - $1.02 Million	18,227 Added 0.4%	4,594,917 $255 Million
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $1.95 Million - $2.68 Million	40,340 Added 0.89%	4,576,690 $232 Million
Q2 2022 Aug 11, 2022	BUY	$57.25 - $86.63 $537,291 - $813,022	9,385 Added 0.21%	4,536,350 $283 Million
Q1 2022 May 11, 2022	BUY	$71.02 - $86.99 $7.92 Million - $9.7 Million	111,520 Added 2.53%	4,526,965 $370 Million
Q4 2021 Feb 11, 2022	BUY	$76.72 - $92.68 $17.7 Million - $21.3 Million	230,330 Added 5.5%	4,415,445 $386 Million
Q3 2021 Nov 12, 2021	BUY	$76.02 - $88.62 $12.3 Million - $14.3 Million	161,390 Added 4.01%	4,185,115 $331 Million
Q2 2021 Aug 10, 2021	BUY	$73.44 - $87.01 $76,377 - $90,490	1,040 Added 0.03%	4,023,725 $338 Million
Q1 2021 May 14, 2021	BUY	$62.9 - $82.41 $4.15 Million - $5.44 Million	65,990 Added 1.67%	4,022,685 $297 Million
Q4 2020 Feb 08, 2021	BUY	$46.01 - $68.74 $9.49 Million - $14.2 Million	206,295 Added 5.5%	3,956,695 $262 Million
Q3 2020 Nov 13, 2020	BUY	$41.91 - $57.81 $8.37 Million - $11.5 Million	199,700 Added 5.62%	3,750,400 $170 Million
Q2 2020 Aug 13, 2020	BUY	$39.87 - $56.9 $44.4 Million - $63.3 Million	1,112,870 Added 45.65%	3,550,700 $171 Million
Q1 2020 May 14, 2020	BUY	$34.22 - $76.49 $34.1 Million - $76.3 Million	997,230 Added 69.22%	2,437,830 $110 Million
Q4 2019 Feb 14, 2020	BUY	$68.92 - $85.27 $63.9 Million - $79.1 Million	927,640 Added 180.84%	1,440,600 $109 Million
Q3 2019 Nov 13, 2019	BUY	$71.74 - $86.35 $2.71 Million - $3.26 Million	37,740 Added 7.94%	512,960 $37.9 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $18.9 Million - $27.7 Million	284,220 Added 148.81%	475,220 $34.2 Million
Q1 2019 May 14, 2019	BUY	$86.15 - $100.49 $9.72 Million - $11.3 Million	112,800 Added 144.25%	191,000 $18.6 Million
Q4 2018 Feb 12, 2019	BUY	$84.14 - $125.42 $6.58 Million - $9.81 Million	78,200 New	78,200 $7.15 Million

Others Institutions Holding LIVN

# of Institutions

296

Shares Held

56.9M

Call Options Held

152K

Put Options Held

49.3K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.96B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Liva Nova PLC Transaction History